Profil
Paolo Galfetti is Chief Executive Officer & Director at APR Applied Pharma Research SA since 1995.
Mr. Galfetti is Chief Business Officer at Mindmaze Therapeutics Holding SA. Former roles include Chief Executive Officer & Director at Farma Resa Imp SRL, Chief Executive Officer & Director at Institute For Pharmacokinetic & Analytical Studies, and Chief Operating Officer at RELIEF THERAPEUTICS Holding SA from 2023 to 2024.
Education includes an undergraduate degree from the University of Bocconi.
Aktive Positionen von Paolo Galfetti
| Unternehmen | Position | Beginn |
|---|---|---|
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Vorstandsvorsitzender | 01.01.1995 |
Ehemalige bekannte Positionen von Paolo Galfetti
| Unternehmen | Position | Ende |
|---|---|---|
Institute For Pharmacokinetic & Analytical Studies | Vorstandsvorsitzender | - |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Vorstandsvorsitzender | - |
| MINDMAZE THERAPEUTICS HOLDING SA | Geschäftsführer | 08.05.2024 |
Ausbildung von Paolo Galfetti
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Health Technology |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Institute For Pharmacokinetic & Analytical Studies |
















